: The Phase 3 MOVE trial demonstrated that palovarotene reduced the volume of new heterotopic ossification (HO) by approximately 62% compared to untreated patients.
Could you clarify if is a dataset for a specific medical study , a local archive , or a software package ? JB_JB.BOYS.rar
Based on related keywords, the following medical report details the most relevant recent research: : The Phase 3 MOVE trial demonstrated that